SCHEMBL6820372

SCHEMBL6820372

O=Cc1cccc2c(C(F)(F)Br)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.41
PIM3 Q86V86 2/20 0.41
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 2/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ERN1 O75460 2/20 0.37
TRIM24 O15164 3/20 0.33
TRIM33 Q9UPN9 3/20 0.33
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 2/20 0.33
PABPC1 P11940 1/20 0.33
HTT P42858 1/20 0.33
TSHR P16473 1/20 0.33
NFKB1 P19838 1/20 0.33
CYP2A6 P11509 3/20 0.32
IMPDH2 P12268 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6819881 0.81 KIF11 (0.39) MEN1KMT2ALMNATDP1KDM4E
SCHEMBL6816433 0.81 MEN1 (0.39) PIM1PIM3MEN1KMT2ALMNA
SCHEMBL4245330 0.78 MEN1 (0.61) MEN1KMT2ALMNATHRBBLM
SCHEMBL3245477 0.74 PIM1 (0.42) PIM1PIM3MEN1KMT2ALMNA
SCHEMBL9671258 0.71 ERN1 (0.57) MEN1KMT2ALMNATHRBBLM
SCHEMBL6816210 0.71 KDM4E (0.35) MEN1KMT2ALMNAKDM4ESMN1; SMN2
SCHEMBL12143561 0.71 ERN1 (0.57) MEN1KMT2ALMNATHRBBLM
SCHEMBL1394290 0.71 MEN1 (0.46) PIM1PIM3MEN1KMT2ALMNA
SCHEMBL17761027 0.71 TAS2R14 (0.44) PIM1PIM3MEN1KMT2ALMNA
SCHEMBL6853771 0.69 NFKB1 (0.44) PIM1PIM3MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0995734-B1 Method for production of halogen-containing aromatic compound NIPPON CATALYTIC CHEM IND (JP) 2004-05-12 EP disclosed
US-6433231-B2 BROMINATION THE CORRESPONDING NAPHTHALENE HALOGEN COMPOUND NIPPON SHOKUBAI CO., LTD. (JP) 2002-08-13 US disclosed
US-20010045350-A1 Method for production of halogen-containing aromatic compound NIPPON SHOKUBAI CO., LTD., A JAPAN CORPORATION 2001-11-29 US disclosed
US-6288290-B1 BROMINATION AND PHOTOBROMINATION OF AROMATIC COMPOUNDS NIPPON SHOKUBAI, CO., LTD. (JP) 2001-09-11 US disclosed
EP-0995734-A1 Method for production of halogen-containing aromatic compound Nippon Shokubai Co., Ltd. (JP) 2000-04-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010045350-A1 Method for production of halogen-containing aromatic compound CBR1, CBR3, DCXR PIM1 3247/4885PIM3 3589/4885MEN1 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.